Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 18, 2018 - Issue 6
Submit an article Journal homepage
3,550
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Fair global drug pricing

Jonathan D. CampbellSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Denver, Colorado, USACorrespondence[email protected]
View further author information
&
Zoltán KalóDepartment of Health Policy and Economics, Institute of Economics, Faculty of Social Sciences, Eötvös Loránd University (ELTE);Syreon Research InstituteORCID Iconhttp://orcid.org/0000-0001-7762-2607View further author information
ORCID Icon
Pages 581-583 | Received 19 Jun 2018, Accepted 12 Sep 2018, Published online: 28 Sep 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sabine Vogler, Maximilian Salcher-Konrad & Katharina Habimana. (2023) Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?. Expert Review of Pharmacoeconomics & Outcomes Research 23:8, pages 867-878.
Read now
Lajos Hornyák, Zsolt Nagy, Lívia Ilku, Zsuzsanna Tálos, Dóra Endrei, István Ágoston, Tímea Csákvári, Nóra Danku, Balázs Répásy & Imre Boncz. (2019) Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary. Expert Review of Pharmacoeconomics & Outcomes Research 19:6, pages 725-731.
Read now

Articles from other publishers (2)

Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Patricia Vella-Bonanno, Michael Ermisch, Steven Simoens, Renata Curi Hauegen, Jolanta Gulbinovic, Angela Timoney, Antony P. Martin, Tanja Mueller, Anna Nachtnebel, Stephen Campbell, Gisbert Selke, Tomasz Bochenek, Celia C. Rothe, Ileana Mardare, Marion Bennie, Jurij Fürst, Rickard E. Malmstrom & Brian Godman. (2019) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. Applied Health Economics and Health Policy 18:1, pages 5-16.
Crossref
Evert-Ben van Veen. (2018) Observational health research in Europe: understanding the General Data Protection Regulation and underlying debate. European Journal of Cancer 104, pages 70-80.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.